Proteome Sciences plc (PRM.L)
- Previous Close
3.5100 - Open
4.3224 - Bid 3.5000 x --
- Ask 4.8000 x --
- Day's Range
3.7500 - 4.6440 - 52 Week Range
2.6520 - 8.7880 - Volume
126,042 - Avg. Volume
149,345 - Market Cap (intraday)
11.069M - Beta (5Y Monthly) -0.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Apr 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. It offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. The company also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers, as well as bioinformatics tools. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
www.proteomics.com35
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PRM.L
Performance Overview: PRM.L
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRM.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRM.L
Valuation Measures
Market Cap
10.36M
Enterprise Value
21.81M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.17
Price/Book (mrq)
--
Enterprise Value/Revenue
4.34
Enterprise Value/EBITDA
-19.18
Financial Highlights
Profitability and Income Statement
Profit Margin
-48.59%
Return on Assets (ttm)
-8.48%
Return on Equity (ttm)
--
Revenue (ttm)
5.03M
Net Income Avi to Common (ttm)
-2.44M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.03M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-576.25k
Company Insights: PRM.L
PRM.L does not have Company Insights